Search Results
Sep 09, 2026, 09:13 ET Fairmont Hotels & Resorts Expands "Special Happens..." Program with New Experiences Across Global Portfolio
Stay. An immersive escape inspired by the property's celebrated musical history. Once frequented by entertainment icons including Frank Sinatra, Nat King Cole, and Liza Minnelli, the iconic hotel invites guests to embrace the glamor of the stage through a personalized styling session, followed
More news about: Fairmont Hotels & Resorts
Sep 09, 2026, 05:00 ET Terapia de edición bases con tBE logra remisión clínica duradera en drepanocitosis y β-talasemia en varios fondos genét
patogénicas varían significativamente entre poblaciones. El equipo desarrolló previamente la técnica tBE de ultra alta precisión Wang et al., Nat Cell Biol, 2021) para editar con precisión la región promotora de HBG1/2 en células madre hematopoyéticas autólogas obtenidas de pacientes,
More news about: CorrectSequence Therapeutics
Sep 08, 2026, 23:30 ET TUTK Helps Indian Security Customers Achieve STQC Cybersecurity Certification
deployment.Secure P2P Connectivity for Devices and VideoRemote video surveillance introduces potential security risks across device pairing, NAT traversal, session establishment, and video transmission. Addressing these risks requires multiple layers of protection, including secure device authentication,
More news about: ThroughTek; TUTK
Sep 08, 2026, 23:30 ET TUTK ने भारतीय सुरक्षा ग्राहकों को STQC साइबर सुरक्षा प्रमाणन प्राप्त करने में सहायता की
कर सकने के तरीके प्रदर्शित करते हैं।उपकरणों और वीडियो के लिए सुरक्षित P2P कनेक्टिविटी दूरस्थ वीडियो निगरानी से उपकरण पेयरिंग, NAT ट्रैवर्सल, सत्र स्थापन और वीडियो ट्रांसमिशन में संभावित सुरक्षा जोखिम उत्पन्न हो सकते हैं। इन जोखिमों से बचने के लिए सुरक्षित उपकरण प्रमाणीकरण, एन्क्रिप्टेड
More news about: ThroughTek; TUTK
Sep 08, 2026, 12:52 ET Cell Stem Cell: Die tBE-vermittelte Base-Editing-Therapie erzielt bei unterschiedlichen genetischen Hintergründen eine dauerhafte klinische Remission bei Sichelzellkrankheit und β-Thalassämie
betroffen. Pathogene Mutationen variieren erheblich zwischen den Populationen. Das Team hatte zuvor den ultrapräzisen tBE (Wang et al., Nat Cell Biol, 2021) entwickelt, um die HBG1/2-Promotorregion in autologen, den Patienten entnommenen HSPCs präzise zu editieren und so die
More news about: CorrectSequence Therapeutics
Sep 08, 2026, 11:52 ET Le « oneworld Loyalty Summit » rassemble des experts pour examiner les dernières tendances et innovations qui façonnent le secteur de la fidélisation
événement d'une journée permettra d'entendre les témoignages de personnalités telles que :Ole Orvér, PDG d' oneworldNat Pieper, directeur commercial d'American AirlinesBrian Kelly, fondateur et PDG de The Points GuySarah Moore, vice-présidente senior
More news about: oneworld Management Company, Inc
Sep 08, 2026, 11:50 ET Der oneworld Loyalty Summit bringt Experten zusammen, um die neuesten Trends und Innovationen zu erörtern, die die Loyalitätslandschaft prägen
Veranstaltung werden führende Persönlichkeiten Einblicke geben, darunter:Ole Orvér, Geschäftsführer von „oneworld"Nat Pieper, Chief Commercial Officer bei American AirlinesBrian Kelly, Gründer und Geschäftsführer von „The Points Guy"Sarah Moore, Senior
More news about: oneworld Management Company, Inc
Sep 08, 2026, 10:41 ET Cell Stem Cell : la thérapie d'édition de bases médiée par tBE permet d'obtenir une rémission clinique durable dans la drépanocytose et la bêta-thalassémie, quel que soit le profil génétique des patients
pathogènes varient considérablement d'une population à l'autre. L'équipe avait précédemment mis au point la technique tBE (Wang et al., Nat Cell Biol, 2021), une méthode d'ultra-haute précision permettant de modifier avec précision la région promotrice HBG1/2 dans des cellules
More news about: CorrectSequence Therapeutics
Sep 08, 2026, 10:11 ET oneworld Loyalty Summit Brings Together Experts to Explore Latest Trends and Innovations Shaping the Loyalty Landscape
for loyalty."The one-day event will feature insights from leaders including:Ole Orvér, CEO of oneworldNat Pieper, Chief Commercial Officer, American AirlinesBrian Kelly, Founder & CEO, The Points GuySarah Moore, Senior Vice President
More news about: oneworld Management Company, Inc
Sep 08, 2026, 09:00 ET IMDELLTRA® IN COMBINATION WITH IMFINZI® DEMONSTRATED LANDMARK IMPROVEMENT IN OVERALL SURVIVAL IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
2022;13(9):2945-2953. doi:10.7150/jca.75622.Sabari JK, Lok BH, Laird JH, Poirier JT, Rudin CM. Unravelling the biology of SCLC: implications for therapy. Nat Rev Clin Oncol. 2017;14(9):549-561. doi:10.1038/nrclinonc.2017.71.Cramer-van der Welle CM, Schramel FMNH, van Leeuwen AS, Groen HJM, van
More news about: Amgen
Sep 08, 2026, 08:00 ET Johnson & Johnson spotlights new neuropsychiatry data across bipolar mania, depression and schizophrenia at Psych Congress 2026
Sanacora G, Zarate C, Krystal J, et al. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov. 2008;7(5):426-437. doi:10.1038/nrd2462Treatment Advocacy Center. Schizophrenia Fact Sheet. Accessed May 2026.
More news about: Johnson & Johnson
Sep 07, 2026, 20:00 ET Cell Stem Cell: tBE-mediated Base Editing Therapy Achieves Durable Clinical Remission in Sickle Cell Disease and β-Thalassemia Across Different Genetic Backgrounds
the ultra-high-precision tBE (Wang et al., Nat Cell Biol, 2021) to precisely edit the HBG1/2 promoter region in autologous HSPCs collected from patients, reactivating γ-globin expression.
More news about: CorrectSequence Therapeutics
Sep 07, 2026, 20:00 ET Cell Stem Cell: tBE-mediated Base Editing Therapy Achieves Durable Clinical Remission in Sickle Cell Disease and β-Thalassemia Across Different Genetic Backgrounds
the ultra-high-precision tBE (Wang et al., Nat Cell Biol, 2021) to precisely edit the HBG1/2 promoter region in autologous HSPCs collected from patients, reactivating γ-globin expression.
More news about: CorrectSequence Therapeutics
Sep 07, 2026, 05:42 ET Nature Biotechnology | Insilico's AI-Driven IPF Candidate Rentosertib Shows Potential for Biological Age Reversal, as Assessed by Six Proteomic Aging Clocks
Galkin, F., Chen, S. et al. Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment. Nat Biotechnol (2026). https://doi.org/10.1038/s41587-026-03286-y
More news about: Insilico Medicine
Sep 03, 2026, 16:30 ET Nation's Largest Gathering of Hispanic Business Decision-Makers Heads to Fort Worth for 47th Annual USHCC National Conference
Fort WorthBret Perkins, Senior Vice President of External and Government Affairs, Comcast CorporationAllen Nye, CEO of OncorNat Pieper, Chief Commercial Officer of American AirlinesRamiro A. Cavazos, President & CEO, United States Hispanic Chamber of CommerceThe
More news about: United States Hispanic Chamber of Commerce
Sep 03, 2026, 11:58 ET LAKE VICTORIA GOLD COMPLETES INITIAL ACCESS ROAD REPAIRS AND ADVANCES SITE EARTHWORKS AT IMWELO GOLD PROJECT
risks.Qualified PersonThe scientific and technical information contained in this news release has been reviewed and approved by David Scott, Pr. Sci. Nat., a Qualified Person as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects. Mr. Scott is a Director and Officer
More news about: Lake Victoria Gold Ltd.
Sep 03, 2026, 09:08 ET Gold Forecast to Reach $4,900 an Ounce as Central Bank Buying Holds
Project contained in this article is derived from disclosure by Lake Victoria Gold Ltd. that has been reviewed and approved by David Scott, Pr. Sci. Nat., registered with the South African Council for Natural Scientific Professions, a Qualified Person as defined by National Instrument 43-101 - Standards
More news about: American News Group
Sep 03, 2026, 03:38 ET Lundbeck to highlight mechanistic insights on bexicaserin's dual mode of action at the European Epilepsy Congress
Greece.Bialer M, et al. Epilepsia. 2026. doi:10.1002/epi.70346.Scheffer IE, et al. Epilepsia. 2025;66:1014–1023.Scheffer IE, et al. Nat Rev Dis Primers. 2024;10:61.Guerrini R, et al. Physiol Rev. 2023;103(1):433–513.ClinicalTrials.gov. NCT06719141.ClinicalTrials.gov.
More news about: H. Lundbeck A/S
Sep 03, 2026, 03:32 ET Lundbeck to highlight mechanistic insights on bexicaserin's dual mode of action at the European Epilepsy Congress
Greece.Bialer M, et al. Epilepsia. 2026. doi:10.1002/epi.70346.Scheffer IE, et al. Epilepsia. 2025;66:1014–1023.Scheffer IE, et al. Nat Rev Dis Primers. 2024;10:61.Guerrini R, et al. Physiol Rev. 2023;103(1):433–513.ClinicalTrials.gov. NCT06719141.ClinicalTrials.gov.
More news about: H. Lundbeck A/S
Aug 31, 2026, 07:00 ET New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults with psoriatic disease and obesity
Corrona Psoriasis Registry. Journal of the American Academy of Dermatology, Volume 86, Issue 1, 68 - 76.4 Proft F, et al. Nat Rev Rheumatol. 2026 Feb;22(2):132-144.5 di Minno MN, et al. Arthritis Care Res (Hoboken). 2013;65(1):141-147. 6
More news about: Eli Lilly and Company
Aug 27, 2026, 08:56 ET Intersignal Opens Braid Jump Kit for Free Public Testing
Aug. 27, 2026 /PRNewswire/ -- Intersignal today announced the public-testing release of Braid Jump Kit 1.5.3rc2, a WAN and NAT traversal sidecar designed to help Braid nodes communicate securely across real-world network boundaries. The release follows a successful end-to-end
More news about: Intersignal
Aug 27, 2026, 07:00 ET LAKE VICTORIA GOLD INTERSECTS 28.71 G/T AU OVER 2.75 M AND 12.20 G/T AU OVER 4.50 M IN SHALLOW AREA C DRILLING AT IMWELO
PersonThe scientific and technical information contained in this news release has been reviewed and approved by David Scott, Pr. Sci. Nat., a Qualified Person as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects. Mr. Scott is a Director and Officer
More news about: Lake Victoria Gold Ltd.
Aug 27, 2026, 02:00 ET AbbVie Submits Regulatory Application to EMA for SKYRIZI® (risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease
bowel disease and its management. Am J Manag Care. 2016 Mar;22(3 Suppl):s51-60.Kaplan G. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015 Dec;12(12):720-7. doi: 10.1038/nrgastro.2015.150.Gajendran M, et al. A comprehensive review and update on
More news about: AbbVie
Aug 25, 2026, 08:30 ET Nektar Announces Publication in The Lancet of Positive Phase 2b REZOLVE-AD 16-Week Induction Results of Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis
receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trials. Nat Commun. 2024; 15, 9230Fanton, C. et al. Selective expansion of regulatory T cells by NKTR-358 in healthy volunteers and patients with systemic
More news about: Nektar Therapeutics
Aug 24, 2026, 08:19 ET Intersignal Demonstrates Cross-Platform Local AI Collaboration as Braid Enters Next Development Phase
Developer feedback shapes roadmap for optional managed NAT traversal, while core LAN and Wi-Fi functionality remains free for local use.FORT LAUDERDALE, Fla., Aug. 24, 2026 /PRNewswire/ -- Intersignal today announced
More news about: Intersignal